Acuta Capital Partners, LLC Vincerx Pharma, Inc. Transaction History

Acuta Capital Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.0 - $0.0 $0 - $0	-260,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$0.0 - $0.0 $0 - $0	-218,401 Reduced 45.65%	260,000 $4.2 Million
Q2 2021 Aug 16, 2021	BUY	$0.0 - $27.0 $0 - $2.28 Million	84,401 Added 21.42%	478,401 $6.21 Million
Q1 2021 May 17, 2021	BUY	$22.6 - $31.0 $8.9 Million - $12.2 Million	394,000 New	394,000 $7.6 Million

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $4.45M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuta Capital Partners, LLC with notifications on news.